查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1571641

核醫設備市場規模、佔有率、趨勢分析報告：2024-2030年按類型、應用、最終用途、地區和細分市場預測

Nuclear Medicine Equipment Market Size, Share & Trends Analysis Report By Type (SPECT, PET, Planar Scintigraphy Systems), By Application (Oncology, Cardiology, Neurology, General Imaging), By End Use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

核醫設備市場成長及趨勢：

Grand View Research, Inc.最新報告顯示，預計到2030年，全球核醫設備市場規模將達到84.7億美元，2024年至2030年複合年成長率為3.1%。

核子醫學利用放射線來診斷和治療疾病。它還包括確定某些器官是否正常運作。在過去的二十年裡，核子醫學技術的快速進步徹底改變了醫療實務。

隨著人們對慢性病早期診斷重要性的認知不斷提高，核醫學診斷檢測在世界各地顯著增加。這從佔世界人口約26%的新興國家的統計數據中可以清楚看出。這些國家每年進行核子醫學診斷檢測的比例為 1.9%。此外，在美國等已開發國家，每年核醫檢查的次數約2,000萬次。很明顯，診斷中核醫和含放射性藥物程序的使用頻率正以每年 10% 以上的速度增加，這表明全世界擴大採用核醫設備。然而，與核子醫學設備相關的高成本和放射學報銷支援不足預計將阻礙市場成長。此外，購買再製造系統以降低成本的趨勢日益明顯，預計將影響現有市場參與者的設備銷售。

核子醫學設備市場報告亮點

  • 由於慢性病診斷越來越偏好SPECT 和 PET 掃描，北美市場預計將出現良好的成長。
  • 北美地區對放射性藥物使用的認知不斷提高以及政府採取的舉措預計將推動使用率的提高。例如，2016年12月，FDA發布了新指南，以實施FDA提出的有關美國人體放射性藥物的配製和重新包裝的政策。
  • 在2023年的市場區隔中，由於全球癌症發生率和盛行率不斷上升，腫瘤學在應用領域佔據最大的市場佔有率。
  • 在日本、中國和印度的推動下，亞太市場預計將出現顯著成長，這些地區核子醫學的使用正在迅速增加。此外，利用基於放射免疫療法的標靶癌症治療來降低癌症和心血管疾病的發生率正在推動市場成長。
  • 主要參與者正在關注新興經濟體的擴張和滲透機會，以實現市場的永續成長。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章全球核子醫學設備市場變數、趨勢與範圍

  • 市場介紹/系統展望
  • 市場規模及成長前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 全球核子醫學設備市場分析工具
    • 波特的分析
    • PESTEL分析

第4章 全球核子醫學設備市場：類型估計與趨勢分析

  • 細分儀表板
  • 核子醫學設備市場：2023年及2030年類型變化分析
  • SPECT
  • PET
  • 平面閃爍閃爍圖術系統

第5章 全球核醫設備市場：應用預估及趨勢分析

  • 細分儀表板
  • 核子醫學設備市場：2023年及2030年應用變化分析
  • 腫瘤學
  • 心臟病學
  • 神經病學
  • 常見影像

第6章 全球核子醫學設備市場：最終用途估計與趨勢分析

  • 細分儀表板
  • 核子醫學設備市場：2023 年和 2030 年最終用途變化分析
  • 醫院
  • 影像診斷中心
  • 其他用途

第7章全球核子醫學設備市場：區域估計與趨勢分析

  • 核醫設備市場佔有率（按地區），2023 年和 2030 年，十億美元
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 科威特

第8章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司分類
  • 企業熱力圖分析
  • 公司簡介
    • GE HealthCare
    • Siemens Healthineers AG
    • Koninklijke Philips NV
    • CANON MEDICAL SYSTEMS CORPORATION
    • TTG IMAGING SOLUTIONS
    • Mediso Ltd.
    • CMR Naviscan
    • Neusoft Corporation.
    • Shenzhen Anke High-tech Co., Ltd.
    • Bracco Imaging SpA
    • Biosensors International Group, Ltd.
簡介目錄
Product Code: GVR-1-68038-413-0

Nuclear Medicine Equipment Market Growth & Trends:

The global nuclear medicine equipment market size is expected to reach a value of USD 8.47 billion by 2030 and is projected to grow at a CAGR of 3.1% from 2024 to 2030, according to a new report by Grand View Research, Inc. Nuclear medicine involves the utilization of radiation to diagnose diseases or treat them. It also involves determining whether specific organs are functioning normally. Over a stretch of the last two decades, rapid technological advancements in nuclear medicine have transformed the medicine practice.

With growing awareness about the importance of early diagnosis of chronic diseases, there has been a noticeable increase in diagnostic nuclear medicine procedures worldwide. This is evident from stats generated from developing countries, which represents about 26% of the world population. These countries conduct diagnostic nuclear medicine tests at a rate of 1.9% per year. In addition, in developed countries such as the U.S., the frequency of nuclear medicine procedures ranges to about 20 million per year. It is evident that the frequency of use of nuclear medicine and procedures involving radiopharmaceuticals in diagnosis is growing at over 10% per year, indicating a rise in adoption of nuclear medicine equipment worldwide. However, high cost associated with nuclear medicine equipment and insufficient reimbursement support for radiology is expected to hinder the growth of the market. In addition, a growing trend of purchasing refurbished systems for cost saving is expected to affect equipment sales of existing market players.

Nuclear Medicine Equipment Market Report Highlights:

  • The North American market is expected to register lucrative growth owing to increasing preference for SPECT and PET scans for diagnosis of chronic diseases
  • Growing awareness and government initiatives pertaining to usage of radiopharmaceuticals in the North American region is expected to boost usage rates. For instance, in December 2016, the FDA issued new guidelines to enforce FDA's proposed policies regarding compounding and repackaging of radiopharmaceuticals for human use in the U.S.
  • Oncology accounted for the largest market share in application segment in the year 2023 owing to the increasing incidence and prevalence of cancer worldwid
  • Asia Pacific market is expected to witness significant growth owing to Japan, China, and India where use of nuclear medicine is increasing at a fast pace. In addition, the usage of radioimmunotherapy-based targeted cancer treatment to counter incidence of cancer and cardiovascular diseases is aiding in the growth of the market
  • The key players are focused on expansion & penetration opportunities in developing and emerging economies to achieve sustainable growth in the market

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Global Nuclear Medicine Equipment Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Global Nuclear Medicine Equipment Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Global Nuclear Medicine Equipment Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Nuclear Medicine Equipment Market: Type Movement Analysis, 2023 & 2030 (USD Billion)
  • 4.3. SPECT
    • 4.3.1. SPECT Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. PET
    • 4.4.1. PET Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Planar Scintigraphy Systems
    • 4.5.1. Planar Scintigraphy Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Global Nuclear Medicine Equipment Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Nuclear Medicine Equipment Market: Application Movement Analysis, 2023 & 2030 (USD Billion)
  • 5.3. Oncology
    • 5.3.1. Oncology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Cardiology
    • 5.4.1. Cardiology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Neurology
    • 5.5.1. Neurology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. General Imaging
    • 5.6.1. General Imaging Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Globe Nuclear Medicine Equipment Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Nuclear Medicine Equipment Market: End Use Movement Analysis, 2023 & 2030 (USD Billion)
  • 6.3. Hospitals
    • 6.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Diagnostic Imaging Centers
    • 6.4.1. Diagnostic Imaging Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Other End Use
    • 6.5.1. Other End Use Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Globe Nuclear Medicine Equipment Market: Regional Estimates & Trend Analysis

  • 7.1. Nuclear Medicine Equipment Market Share, By Region, 2023 & 2030, USD Billion
  • 7.2. North America
    • 7.2.1. North America Nuclear Medicine Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. U.S. Nuclear Medicine Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Canada Nuclear Medicine Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.4. Mexico
      • 7.2.4.1. Mexico Nuclear Medicine Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Nuclear Medicine Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.2. U.K.
      • 7.3.2.1. U.K. Nuclear Medicine Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Germany Nuclear Medicine Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.4. Italy
      • 7.3.4.1. Italy Nuclear Medicine Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.5. Spain
      • 7.3.5.1. Spain Nuclear Medicine Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.6. Denmark
      • 7.3.6.1. Denmark Nuclear Medicine Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.7. Sweden
      • 7.3.7.1. Sweden Nuclear Medicine Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.8. Norway
      • 7.3.8.1. Norway Nuclear Medicine Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Nuclear Medicine Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. China
      • 7.4.2.1. China Nuclear Medicine Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Japan
      • 7.4.3.1. Japan Nuclear Medicine Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. India Nuclear Medicine Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.5. South Korea
      • 7.4.5.1. South Korea Nuclear Medicine Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.6. Australia
      • 7.4.6.1. Australia Nuclear Medicine Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.7. Thailand
      • 7.4.7.1. Thailand Nuclear Medicine Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Nuclear Medicine Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Brazil Nuclear Medicine Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Argentina
      • 7.5.3.1. Argentina Nuclear Medicine Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Middle East and Africa
    • 7.6.1. Middle East and Africa Nuclear Medicine Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. Saudi Arabia
      • 7.6.2.1. Saudi Arabia Nuclear Medicine Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. UAE
      • 7.6.3.1. UAE Nuclear Medicine Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. South Africa
      • 7.6.4.1. South Africa Nuclear Medicine Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. Kuwait Nuclear Medicine Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis by Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Heat Map Analysis
  • 8.4. Company Profiles
    • 8.4.1. GE HealthCare
      • 8.4.1.1. Participant's Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Recent Developments/ Strategic Initiatives
    • 8.4.2. Siemens Healthineers AG
      • 8.4.2.1. Participant's Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Recent Developments/ Strategic Initiatives
    • 8.4.3. Koninklijke Philips N.V.
      • 8.4.3.1. Participant's Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Recent Developments/ Strategic Initiatives
    • 8.4.4. CANON MEDICAL SYSTEMS CORPORATION
      • 8.4.4.1. Participant's Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Recent Developments/ Strategic Initiatives
    • 8.4.5. TTG IMAGING SOLUTIONS
      • 8.4.5.1. Participant's Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Recent Developments/ Strategic Initiatives
    • 8.4.6. Mediso Ltd.
      • 8.4.6.1. Participant's Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Recent Developments/ Strategic Initiatives
    • 8.4.7. CMR Naviscan
      • 8.4.7.1. Participant's Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Recent Developments/ Strategic Initiatives
    • 8.4.8. Neusoft Corporation.
      • 8.4.8.1. Participant's Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Recent Developments/ Strategic Initiatives
    • 8.4.9. Shenzhen Anke High-tech Co., Ltd.
      • 8.4.9.1. Participant's Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Recent Developments/ Strategic Initiatives
    • 8.4.10. Bracco Imaging S.p.A.
      • 8.4.10.1. Participant's Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Recent Developments/ Strategic Initiatives
    • 8.4.11. Biosensors International Group, Ltd.
      • 8.4.11.1. Participant's Overview
      • 8.4.11.2. Financial Performance
      • 8.4.11.3. Product Benchmarking
      • 8.4.11.4. Recent Developments/ Strategic Initiatives